Showing results (1151-1160 of 1,767) with videos related to

Sort By:
Pageof 177
Maternal and Child Health Journal|March 2, 2022
Effects of Smoking Reduction and Cessation on Birth Outcomes in a Scheduled Gradual Reduction Cessation TrialDanielle L Kennedy, Pauline Lyna, Xiaomei Gao, et al.
Chest|May 4, 2019
Infectious Disease Hospitalizations: United States, 2001 to 2014Jordan L Kennedy, Dana L Haberling, Chaorui C Huang, et al.
Schizophrenia Research|July 31, 2024
Analysis of the complement component C4 gene with schizophrenia subphenotypesCheng C Chen, Joshua Howie, Mahbod Ebrahimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2010
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancerA Schneeweiss, F Marmé, A Ruiz, et al.
Genes, Brain, and Behavior|May 17, 2007
Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorderJ Lee, N Laurin, J Crosbie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantationD Avigan, Z Wu, J Gong, et al.
Molecular Psychiatry|December 1, 1996
DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorderH Nicolini, C Cruz, B Camarena, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 13, 2007
Patient-reported outcomes to support medical product labeling claims: FDA perspectiveDonald L Patrick, Laurie B Burke, John H Powers, et al.
Human Heredity|September 1, 1993
New polymorphism for the human serotonin 1D receptor variant (5-HT1D beta) not linked to schizophrenia in five Canadian pedigreesD G Sidenberg, A S Bassett, L Demchyshyn, et al.
American Journal of Medical Genetics|March 29, 2002
The norepinephrine transporter gene and attention-deficit hyperactivity disorderCathy L Barr, Jamie Kroft, Yu Feng, et al.
Pageof 177